Riverhead Capital Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Riverhead Capital Management's IDXX Position: Q3 2019 in Review
Riverhead Capital Management reduced its Idexx Laboratories (IDXX) stake by 10% in Q3 2019, selling an estimated $41.7K and leaving 1,300 shares worth $354K. The position accounts for 0.01% of the portfolio, ranked #882.
Riverhead Capital Management first reported a position in IDXX in Q3 2015 and has held it in 17 quarters since. The position peaked at $1.3M in Q4 2015. 720 funds tracked by Wall St. Rank hold IDXX as of Q3 2019.
- Riverhead Capital Management held 1,300 shares of Idexx Laboratories worth $354K as of Q3 2019.
- Riverhead Capital Management sold 150 Idexx Laboratories shares in Q3 2019, an estimated $41.7K.
- Idexx Laboratories made up 0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #882 holding.
- Riverhead Capital Management first reported a position in Idexx Laboratories in Q3 2015 and has held it in 17 quarters since.
- Riverhead Capital Management's Idexx Laboratories position peaked at $1.3M in Q4 2015.
- 720 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2019.
Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.